BULLFROG AI HOLDINGS, INC. Amortization of Debt Discount (Premium)
BULLFROG AI HOLDINGS, INC. (BFRG) reported Amortization of Debt Discount (Premium) of $20.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2025-03-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:AmortizationOfDebtDiscountPremium · last filed 2025-03-14
- BULLFROG AI HOLDINGS, INC. amortization of debt discount (premium) for the quarter ending 2023-12-31 was $0.00, a 100.00% decline year-over-year.
- BULLFROG AI HOLDINGS, INC. amortization of debt discount (premium) for the quarter ending 2023-09-30 was $0.00, a 100.00% decline year-over-year.
- BULLFROG AI HOLDINGS, INC. amortization of debt discount (premium) for the quarter ending 2022-12-31 was $39.43K.
- BULLFROG AI HOLDINGS, INC. amortization of debt discount (premium) for the quarter ending 2022-09-30 was $98.84K.
- BULLFROG AI HOLDINGS, INC. amortization of debt discount (premium) for fiscal 2023 was $20.00K, a 90.67% decline from fiscal 2022.
- BULLFROG AI HOLDINGS, INC. amortization of debt discount (premium) for fiscal 2022 was $214.43K, a 1593.08% increase from fiscal 2021.
- BULLFROG AI HOLDINGS, INC. amortization of debt discount (premium) for fiscal 2021 was $12.66K.
| Period end | Amortization of Debt Discount (Premium) 3 month | Amortization of Debt Discount (Premium) 6 month | Amortization of Debt Discount (Premium) 9 month | Amortization of Debt Discount (Premium) 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-14 | $0.00 derived: sum of 2 quarters · filed 2025-03-14 | $20.00K 10-K · filed 2025-03-14 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $20.00K 10-Q · filed 2024-11-08 | ||
| 2023-06-30 | $20.00K 10-Q · filed 2024-08-07 | |||
| 2022-12-31 | $39.43K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $138.27K derived: sum of 2 quarters · filed 2024-03-29 | $210.40K derived: sum of 3 quarters · filed 2024-03-29 | $214.43K 10-K · filed 2024-03-29 |
| 2022-09-30 | $98.84K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $170.97K derived: sum of 2 quarters · filed 2023-11-14 | $175.00K 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $72.13K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $76.16K 10-Q · filed 2023-08-14 | ||
| 2022-03-31 | $4.03K 10-Q · filed 2023-05-24 | |||
| 2021-12-31 | $12.66K 10-K · filed 2023-04-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B |